Creating a vaccine to protect against coronaviruses
DEVELOPMENT OF A VACCINE CANDIDATE FOR CORONAVIRUSES
This study is working on a new vaccine to help protect against coronaviruses, which cause illnesses like COVID-19, so that we can be better prepared for any future outbreaks and keep people safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10912982 on NIH RePORTER |
What this research studies
This research focuses on developing a vaccine candidate specifically targeting coronaviruses, which are responsible for various infectious diseases. The approach includes formulating and manufacturing vaccine components, conducting stability tests, and evaluating the vaccine's effectiveness and safety through nonclinical studies in animal models. The ultimate goal is to prepare for potential outbreaks by ensuring the vaccine is ready for clinical trials and regulatory approval. Patients may benefit from this research as it aims to provide a preventive measure against future coronavirus outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of exposure to coronaviruses, including healthcare workers and those in close contact with infected individuals.
Not a fit: Patients who are not at risk of exposure to coronaviruses or those who have already been vaccinated against them may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that protects patients from severe illnesses caused by coronaviruses.
How similar studies have performed: Previous research on vaccine development for coronaviruses has shown promise, particularly in the context of the COVID-19 pandemic, indicating that this approach is both relevant and potentially effective.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.